Contrast-enhanced sonography. Therapy control of radiofrequency ablation and transarterial chemoembolization of hepatocellular carcinoma

被引：0
|
作者：
Jung, E. M. [1 ]
Uller, W. [1 ]
Stroszczynski, C. [1 ]
Clevert, D. -A. [2 ]
机构：
[1] Univ Klinikum Regensburg, Inst Rontgendiagnost, D-93053 Regensburg, Germany
[2] Klinikum Ludwig Maximilians Univ, Inst Klin Radiol, Munich, Germany
来源：
RADIOLOGE | 2011年 / 51卷 / 06期
关键词：
Tumor perfusion; Contrast-enhanced ultrasound (CEUS); Hepatocellular carcinoma (HCC); Transarterial chemoembolization (TACE); Radiofrequency ablation (RFA); FOCAL LIVER-LESIONS; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; DEGUM MULTICENTER TRIAL; COMPUTED-TOMOGRAPHY; CLINICAL-PRACTICE; ULTRASOUND CEUS; IMAGE FUSION; CT; TUMORS; ULTRASONOGRAPHY;
D O I：
10.1007/s00117-010-2101-y
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Due to the imaging of dynamic perfusion, hepatocellular carcinoma can be detected with a sensitivity of > 90% using contrast-enhanced sonography. The characterization of liver tumors with contrast-enhanced sonography is comparable to the diagnostic accuracy of contrast-enhanced computed tomography. The dynamic detection of microvascularization with contrast-enhanced sonography allows the differentiation between vascularized tumors and non-vascularized necrotic lesions before, during and after transarterial chemoembolization or percutaneous radiofrequency ablation. Image fusion with volume navigation can be useful in the follow-up control.
引用
收藏
页码：462 / 468
页数：7
相关论文
共 50 条
  • [21] Diagnostic Efficacy of Contrast-Enhanced MRI in Detecting Residual or Recurrent Hepatocellular Carcinoma After Transarterial Chemoembolization: A Systematic Review and Meta-analysis
    Liu, Hai-Feng
    Zou, Li-Qiu
    Lu, Xing-Ru
    Sheng, Ye
    Wang, Qing
    Ding, Jiu-Le
    Shi, Li
    Liu, Shui-Qing
    Xing, Wei
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2020, 52 (04) : 1019 - 1028
  • [22] The Application Comparison of Contrast-Enhanced Ultrasound and Contrast-Enhanced Computed Tomography in Radiofrequency Ablation Treatment for Hepatocellular Carcinoma
    Liu, Zhen
    Wang, Xiaofei
    Xing, Lei
    Pan, Yan
    Huang, Shengchuan
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2019, 34 (10) : 621 - 625
  • [23] Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma
    Jia-Yan Ni
    Shan-Shan Liu
    Lin-Feng Xu
    Hong-Liang Sun
    Yao-Ting Chen
    World Journal of Gastroenterology, 2013, (24) : 3872 - 3882
  • [24] Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma
    Ni, Jia-Yan
    Liu, Shan-Shan
    Xu, Lin-Feng
    Sun, Hong-Liang
    Chen, Yao-Ting
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (24) : 3872 - 3882
  • [25] Radiofrequency Ablation Combined With Transarterial Chemoembolization for Specially Located Small Hepatocellular Carcinoma
    Yuan, Wei
    Yang, Min-Jie
    Xu, Jiang
    Yan, Zhi-Ping
    Liu, Rong
    Qu, Xu-Dong
    Wang, Jian-Hua
    Qian, Sheng
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2018, 17 : 1 - 8
  • [26] Accurate prediction of responses to transarterial chemoembolization for patients with hepatocellular carcinoma by using artificial intelligence in contrast-enhanced ultrasound
    Liu, Dan
    Liu, Fei
    Xie, Xiaoyan
    Su, Liya
    Liu, Ming
    Xie, Xiaohua
    Kuang, Ming
    Huang, Guangliang
    Wang, Yuqi
    Zhou, Hui
    Wang, Kun
    Lin, Manxia
    Tian, Jie
    EUROPEAN RADIOLOGY, 2020, 30 (04) : 2365 - 2376
  • [27] Outcome of transarterial chemoembolization monotherapy, and in combination with percutaneous ethanol injection, or radiofrequency ablation therapy for hepatocellular carcinoma
    Kirikoshi, Hiroyuki
    Saito, Satoru
    Yoneda, Masato
    Fujita, Koji
    Mawatari, Hironori
    Uchiyama, Takashi
    Higurashi, Takuma
    Goto, Ayumu
    Takahashi, Hirokazu
    Abe, Yasunobu
    Inamori, Masahiko
    Kobayashi, Noritoshi
    Kubota, Kensuke
    Sakaguchi, Takashi
    Ueno, Norio
    Nakajima, Atsushi
    HEPATOLOGY RESEARCH, 2009, 39 (06) : 553 - 562
  • [28] Sorafenib in combination with transarterial chemoembolization and radiofrequency ablation in the treatment for unresectable hepatocellular carcinoma
    Li, Yong
    Zheng, You-Bing
    Zhao, Wei
    Liu, Bing
    Hu, Bao-Shan
    He, Xu
    Huang, Jian-Wen
    Lu, Li-Gong
    MEDICAL ONCOLOGY, 2013, 30 (04)
  • [29] Combining Transarterial Chemoembolization With Radiofrequency Ablation for Hepatocellular Carcinoma: One Step Forward?
    Zhu, Andrew X.
    Salem, Riad
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04) : 406 - 408
  • [30] Medium or Large Hepatocellular Carcinoma: Sorafenib Combined with Transarterial Chemoembolization and Radiofrequency Ablation
    Zhu, Kangshun
    Huang, Jingjun
    Lai, Lisha
    Huang, Wensou
    Cai, Mingyue
    Zhou, Jingwen
    Guo, Yongjian
    Chen, Junwei
    RADIOLOGY, 2018, 288 (01) : 300 - 307
12345